Stock Events

Stock Events

BiomX 

$0.142100
28
-$0.00-0.28% Thursday 20:00
-$0.00-1.48%Thursday 23:41After hours

Statistics

Day High
0.14
Day Low
0.1388
52W High
12.29
52W Low
0.119
Volume
1,055
Avg. Volume
-
Mkt Cap
3.8M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-5.61
-3.8
-2
-0.19
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-36.2MNet Income

Analyst Ratings

0.00Average Price Target
The highest estimate is 0.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PHGE. It's not an investment recommendation.
Apple
8
AAPL
Intel
8
INTC
Microsoft
7
MSFT
Amazon
7
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.58B
CRISPR Therapeutics is involved in gene editing, a technology that can be applied to develop therapies similar to BiomX's phage-based treatments.
Editas Medicine
EDIT
Mkt Cap485.31M
Editas Medicine operates in the gene editing space, directly competing with BiomX's approach to treating diseases by targeting specific genetic elements.
Intellia Therapeutics
NTLA
Mkt Cap1.8B
Intellia Therapeutics is another key player in the CRISPR/Cas9 gene editing field, offering potential competition in developing genetic treatments.
Beam Therapeutics
BEAM
Mkt Cap3.03B
Beam Therapeutics uses base editing, a form of gene editing, presenting competition in the precision genetic medicine space.
Voyager Therapeutics
VYGR
Mkt Cap218.13M
Voyager Therapeutics specializes in gene therapy, particularly for neurodegenerative diseases, which could compete with BiomX's phage therapy in certain applications.
Fate Therapeutics
FATE
Mkt Cap291.16M
Fate Therapeutics is working on programmed cellular immunotherapies, a different but competing approach to treating diseases at the genetic level.
Regenxbio
RGNX
Mkt Cap637.69M
REGENXBIO is a leader in gene therapy, using its NAV Technology Platform to develop treatments that could compete with BiomX's offerings.

About

BiomX Inc is a company focused on acquiring and further developing technologies that identify, track, and counter physical threats across defense, security, critical infrastructure, and first-response sectors. The Company's portfolio is built around the growing need for earlier and more accurate threat detection, particularly as UAVs and other autonomous systems play a larger role in defense and homeland security.
Show more...
CEO
Michael Oster
Employees
20
Country
United States
ISIN
US09090D5095

Listings

XASE
US
PHGE
BOATS
BOATS
PHGE.BOATS

0 Comments

Share your thoughts

FAQ

What is BiomX stock price today?▼
The current price of PHGE is $0.14 USD — it has decreased by -0.28% in the past 24 hours. Watch BiomX stock price performance more closely on the chart.
What is BiomX stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XASE exchange BiomX stocks are traded under the ticker PHGE.
Is BiomX stock price growing?▼
PHGE stock has risen by +2.97% compared to the previous week, the month change is a -22.35% fall, over the last year BiomX has showed a -98.55% decrease.
What is BiomX market cap?▼
Today BiomX has the market capitalization of 3.8M
When is the next BiomX earnings date?▼
BiomX is going to release the next earnings report on November 12, 2026.
What is BiomX revenue for the last year?▼
BiomX revenue for the last year amounts to 0 USD.
What is BiomX net income for the last year?▼
PHGE net income for the last year is -36.2M USD.
How many employees does BiomX have?▼
As of September 04, 2026, the company has 20 employees.
In which sector is BiomX located?▼
BiomX operates in the Manufacturing sector.
When did BiomX complete a stock split?▼
The last stock split for BiomX was on November 25, 2025 with a ratio of 1:19.
Where is BiomX headquartered?▼
BiomX is headquartered in DOVER, United States.